Amgen Inc. (AMGN): Price and Financial Metrics

Amgen Inc. (AMGN): $268.14

1.50 (-0.56%)

POWR Rating

Component Grades








Add AMGN to Watchlist
Sign Up

Industry: Biotech




#17 of 342

in industry

AMGN Price/Volume Stats

Current price $268.14 52-week high $288.46
Prev. close $269.64 52-week low $211.71
Day low $267.62 Volume 315,667
Day high $271.13 Avg. volume 2,449,359
50-day MA $270.03 Dividend yield 3.21%
200-day MA $246.34 Market Cap 143.50B

AMGN Stock Price Chart Interactive Chart >


  • Quality is the dimension where AMGN ranks best; there it ranks ahead of 96.14% of US stocks.
  • AMGN's strongest trending metric is Sentiment; it's been moving up over the last 177 days.
  • AMGN's current lowest rank is in the Momentum metric (where it is better than 6.74% of US stocks).

AMGN Stock Summary

  • With a market capitalization of $143,058,438,397, AMGEN INC has a greater market value than 98.71% of US stocks.
  • AMGEN INC's stock had its IPO on January 1, 1986, making it an older stock than 93.05% of US equities in our set.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 14.27 for AMGEN INC; that's greater than it is for 95.58% of US stocks.
  • Stocks that are quantitatively similar to AMGN, based on their financial statements, market capitalization, and price volatility, are PFE, TXN, GILD, RTX, and NFLX.
  • Visit AMGN's SEC page to see the company's official filings. To visit the company's web site, go to

AMGN Valuation Summary

  • In comparison to the median Healthcare stock, AMGN's price/sales ratio is 217.65% higher, now standing at 5.4.
  • Over the past 243 months, AMGN's price/sales ratio has gone down 4.4.

Below are key valuation metrics over time for AMGN.

Stock Date P/S P/B P/E EV/EBIT
AMGN 2023-11-03 5.4 18.9 19.1 15.2
AMGN 2023-11-02 5.3 18.6 18.9 15.0
AMGN 2023-11-01 5.2 18.2 18.5 14.7
AMGN 2023-10-31 5.1 17.9 18.1 14.5
AMGN 2023-10-30 5.3 20.8 17.6 14.9
AMGN 2023-10-27 5.3 20.6 17.5 14.8

AMGN Growth Metrics

    The 3 year revenue growth rate now stands at 10.8%.
  • The 3 year net cashflow from operations growth rate now stands at -10.5%.
  • Its 2 year revenue growth rate is now at 9.81%.
Over the past 52 months, AMGN's revenue has gone up $3.004e+09.

The table below shows AMGN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 26,323 9,721 6,552
2022-09-30 26,330 9,880 6,835
2022-06-30 26,384 9,320 6,576
2022-03-31 26,316 9,321 5,723
2021-12-31 25,979 9,261 5,893
2021-09-30 25,767 8,606 5,609

AMGN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • AMGN has a Quality Grade of A, ranking ahead of 98.04% of graded US stocks.
  • AMGN's asset turnover comes in at 0.412 -- ranking 113th of 682 Pharmaceutical Products stocks.
  • UTHR, NBY, and AERI are the stocks whose asset turnover ratios are most correlated with AMGN.

The table below shows AMGN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.412 0.754 0.169
2021-06-30 0.408 0.753 0.169
2021-03-31 0.395 0.756 0.196
2020-12-31 0.400 0.758 0.206
2020-09-30 0.398 0.767 0.220
2020-06-30 0.395 0.782 0.225

AMGN Price Target

For more insight on analysts targets of AMGN, see our AMGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $250.00 Average Broker Recommendation 1.78 (Moderate Buy)

Amgen Inc. (AMGN) Company Bio

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. Amgen's Thousand Oaks staff in 2017 numbered 5,125 (7.5% of total city employment) and included hundreds of scientists, making Amgen the largest employer in Ventura County. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology. (Source:Wikipedia)  

AMGN Latest News Stream

Event/Time News Detail
Loading, please wait...

AMGN Latest Social Stream

Loading social stream, please wait...

View Full AMGN Social Stream

Latest AMGN News From Around the Web

Below are the latest news stories about AMGEN INC that investors may wish to consider to help them evaluate AMGN as an investment opportunity.


Amgen (NASDAQ:AMGN) will present at the Evercore ISI HealthCONx Conference at 9:10 a.m. EST on Wednesday, Nov. 29, 2023. Peter H. Griffith, executive vice president and chief financial officer at Amgen, and Paul Burton, senior vice president and chief medical officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

Yahoo | November 22, 2023

Billionaire Steven Cohen’s Top High Dividend Stock Picks

In this article, we discuss billionaire Steve Cohen’s top high-dividend stock picks. You can skip our detailed analysis of Point72 Asset Management’s holding and recent developments, and go directly to read Billionaire Steven Cohen’s Top 5 High Dividend Stock Picks. Steve Cohen is a prominent figure in the world of finance and investing, known for […]

Yahoo | November 21, 2023

20 Most Valuable Healthcare Companies in the World

In this article, we will look into the 20 most valuable healthcare companies in the world. If you want to skip our detailed analysis, you can go directly to the 5 Most Valuable Healthcare Companies in the World. Healthcare Services Industry: A Market Analysis According to a report by Verified Market Research, the global healthcare […]

Yahoo | November 20, 2023

18 Best-Performing Dow Stocks in 2023

In this article, we will take a look at the 18 best-performing Dow stocks in 2023. To see more such companies, go directly to 5 Best-Performing Dow Stocks in 2023. The economy and stock markets have defied almost every prediction and estimate in 2023. When the year started there was almost a consensus among notable […]

Yahoo | November 19, 2023

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Yahoo | November 17, 2023

Read More 'AMGN' Stories Here

AMGN Price Returns

1-mo 3.61%
3-mo 5.27%
6-mo 24.93%
1-year -2.97%
3-year 31.09%
5-year 50.02%
YTD 5.63%
2022 20.43%
2021 0.87%
2020 -1.99%
2019 27.60%
2018 15.23%

AMGN Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full AMGN Dividend History

Continue Researching AMGN

Want to see what other sources are saying about Amgen Inc's financials and stock price? Try the links below:

Amgen Inc (AMGN) Stock Price | Nasdaq
Amgen Inc (AMGN) Stock Quote, History and News - Yahoo Finance
Amgen Inc (AMGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!